meglumine has been researched along with Carcinoma, Ehrlich Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffmann, EK; Klausen, TK; Pedersen, SF; Preisler, S | 1 |
| Akine, Y; Kanda, K; Kobayashi, T; Satoh, M; Tokita, N; Tokuuye, K | 1 |
2 other study(ies) available for meglumine and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Monovalent ions control proliferation of Ehrlich Lettre ascites cells.
Topics: Animals; Anions; Calcium; Carcinoma, Ehrlich Tumor; Cations, Monovalent; Cell Membrane; Cell Membrane Permeability; Cell Proliferation; Cells, Cultured; Chloride Channels; Chlorides; G1 Phase; Hydrogen-Ion Concentration; Meglumine; Potassium; Protein Transport; Resting Phase, Cell Cycle; S Phase; Sodium; Sodium-Hydrogen Exchangers; Water | 2010 |
Electron-equivalent dose for the effect of gadolinium neutron capture therapy on the growth of subcutaneously-inoculated Ehrlich tumor cells in mice.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Division; Drug Combinations; Gadolinium DTPA; Male; Meglumine; Mice; Mice, Inbred ICR; Neutron Capture Therapy; Organometallic Compounds; Pentetic Acid; Radiotherapy Dosage | 1993 |